| NCT ID | NCT06594913 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Chapel Hill |
| Condition | Anorexia Nervosa |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2024-10-28 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2024-10-28 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Eligibility Criteria
Inclusion Criteria: * A lifetime history of anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorders or no history of any disordered eating behavior, based on DSM-5 criteria algorithms * Age 12-99 years, depending on country. (US enrollment age is 18-99) Exclusion Criteria: * History of subthreshold disordered eating behaviors.
Contact & Investigator
Cynthia Bulik, PhD
PRINCIPAL INVESTIGATOR
University of North Carolina, Chapel Hill
Frequently Asked Questions
Who can join the NCT06594913 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 99 Years, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06594913 currently recruiting?
Yes, NCT06594913 is actively recruiting participants. Contact the research team at laura_thornton@med.unc.edu for enrollment information.
Where is the NCT06594913 trial being conducted?
This trial is being conducted at Chapel Hill, United States, Brisbane, Australia, Monterrey, Mexico, Christchurch, New Zealand and 1 additional location.
Who is sponsoring the NCT06594913 clinical trial?
NCT06594913 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Cynthia Bulik, PhD at University of North Carolina, Chapel Hill. The trial plans to enroll 20,000 participants.